Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed. AMENDMENT #2 TO EXCLUSIVE...Exclusive License Agreement • February 26th, 2021 • Connect Biopharma Holdings LTD • Pharmaceutical preparations
This Amendment #2 (this “Amendment”) is entered into as of February 23, 2018 (the “Amendment Effective Date”) by and between Arena Pharmaceuticals, Inc. (“Licensor”) and Connect Biopharm LLC (“Company”), and modifies the Exclusive License Agreement dated June 19, 2012 by and between the parties, as amended (the “Existing Agreement” and together with this Amendment, the “Agreement”).
Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed AMENDMENT #3 TO EXCLUSIVE...Exclusive License Agreement • February 26th, 2021 • Connect Biopharma Holdings LTD • Pharmaceutical preparations
This Amendment #3 (this “Amendment”) is entered into as of November 19, 2020 (the “Amendment Effective Date”), by and between Arena Pharmaceuticals, Inc. (“Licensor”) and Connect Biopharm LLC (“Company”), and modifies the Exclusive License Agreement, dated June 19, 2012, by and between the parties, as amended (the “Existing Agreement”, and together with this Amendment, the “Agreement”).
House Lease ContractHouse Lease • February 26th, 2021 • Connect Biopharma Holdings LTD • Pharmaceutical preparations
In accordance with the “Contract Law of the People’s Republic of China” and relevant provisions, in order to define the rights and obligations of the Lessor and the Lessee, Party A and Party B hereby sign this Contract upon negotiated consensus.
Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed. EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • February 26th, 2021 • Connect Biopharma Holdings LTD • Pharmaceutical preparations • California
THIS EXCLUSIVE LICENSE AGREEMENT (the “Agreement”) is entered into as of June 19, 2012 (the “Effective Date”) by and between ARENA PHARMACEUTICALS, INC., located at 6166 Nancy Ridge Drive, San Diego, California, 92121, USA (“Licensor”), and CONNECT BIOPHARM LLC, a California limited liability company, located at 4128 Via Candidiz, Suite 145, San Diego, California, 92130, USA (“Company”).
House Lease ContractHouse Lease • February 26th, 2021 • Connect Biopharma Holdings LTD • Pharmaceutical preparations
In accordance with the “ Contract Law of the People’s Republic of China” and relevant provisions, in order to define the rights and obligations of the Lessor and the Lessee, Party A and Party B hereby sign this Contract upon negotiated consensus.
February 26, 2021 CONNECT BIOPHARMA HONGKONG LIMITED and WUBIN PAN EXECUTIVE EMPLOYMENT AGREEMENTEmployment Agreement • February 26th, 2021 • Connect Biopharma Holdings LTD • Pharmaceutical preparations • Hong Kong
EMPLOYMENT AGREEMENTEmployment Agreement • February 26th, 2021 • Connect Biopharma Holdings LTD • Pharmaceutical preparations • California
THIS EMPLOYMENT AGREEMENT (this “Agreement”) is entered into by and between Connect Biopharm LLC (the “Company”) and its affiliates (the “Company Group”), and Dr. Zheng Wei (“Executive”), and shall be effective as of January 1, 2021 (the “Effective Date”).
SECOND AMENDED AND RESTATED SHAREHOLDERS AGREEMENTSecond Amended and Restated Shareholders Agreement • February 26th, 2021 • Connect Biopharma Holdings LTD • Pharmaceutical preparations • Hong Kong
NOW, THEREFORE, in consideration of the foregoing recitals, the mutual promises hereinafter set forth, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties intending to be legally bound hereto hereby agree as follows:
